Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat

Circulation

Volumn 95, Issue 12, 1997, Pages 2614-2616

  Lemström, Karl ^a   Sihvola, Roope ^a   Bruggeman, Cathrien ^a   Häyry, Pekka ^a   Koskinen, Petri ^a  

^a NONE

Author keywords

Ganciclovir; Transplantation; Viruses

Indexed keywords

GANCICLOVIR;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HEART GRAFT; INFECTION RISK; NONHUMAN; OPEN READING FRAME; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN PHOSPHORYLATION; RAT; VASCULAR DISEASE; VIRUS INFECTION;

EID: 0030950625     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.12.2614     Document Type: Article

References (19)

1. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989;261:3561-3566.
2. Loebe M. Schüler S, Ortwin Z, Warnecke H, Fleck E, Hetzer R. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant, 1990;9:707-711.
3. McDonald K, Rector TS, Braunlin EA, Kubo SH, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol. 1989;64:359-362.
4. Koskinen PK, Krogerus LA, Nieminen MS, Mattila SP, Häyry PJ, Lautenschlager IT. Quantitation of cytomegalovirus infection asso- ciated histological findings in endomyocardial biopsies of heart allografts. J Heart Lung Transplant. 1993;12:343-354.
5. Lemström KB, Burning JH, Bruggeman CA, Lautenschlager IT, Häyry PJ. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest. 1993;92:549-558
6. Lemströ K, Koskinen P, Krogerus L, Daemen M, Bruggeman C, Häyry P. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation. 1995;92:2594-2604.
7. Speir E, Modali R, Huang E-S, Leon MB, Shawl F, Finkel T, Epstein SE. Potential rule of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
8. Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis. Eur Heart. J. 1993;14(suppl K):30-38.
9. Crumpacker CS. Ganciclovir. N Engl J Med. 1996;335:721-729.
10. Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis. 1988;10:S490-S494.
11. Littler E, Stuart AD, Chee MS. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir, Nature. 1992;358:160-162.
12. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 1992;358:162-164.
13. Soghikian MV, Valentine VG, Berry GJ, Patel HR, Robbins RC, Theodore J. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. J. Heart Lung Transplant. 1996;15:881-887.
14. Hollander M, Wolfe DA. Non-parametric Statistical Methods. New York, NY: John Wiley & Sons; 1973.
15. Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM, Richenbacher WE, Millar RG, DuMond C, DeAmond B, Sullivan V, Cheney T. Buhles W, Stinson EB. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med. 1992;326:1182-1186.
16. Lemström KB, Bruning JH, Bruggeman CA, Koskinen PK, Aho PT, Yilmaz S, Lautenschlager IT, Häyry PJ. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Circulation. 1994;90:1969-1978.
17. Koskinen PK, Lemström KB, Bruggeman CA, Lautenschlager IT, Häyry PJ. Acute Cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall; a possible linkage with enhanced allograft arteriosclerosis. Am J Pathol. 1994;144:41-50.
18. Lemström KB, Aho Päivi, Bruggeman CA, Häyry PJ. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-β1 in rat aortic allografts: possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arterioscler Thromb. 1994;14:2043-2052.
19. Koyama N, Hart CE, Clowes AW. Different functions of the platelet-derived growth factor-α and -β receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res. 1994;75:682-691.